← All Arcadia Biosciences, INC filings

Arcadia Biosciences, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
RKDA
Arcadia Biosciences, INC
10-K/A: Arcadia Biosciences Files Amendment No. 1 to Form 10-K, Providing Detailed Information on Directors, Executive Compensation, and Corporate Governance
Arcadia Biosciences files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.
NASDAQ
RKDA
Arcadia Biosciences, INC
10-K: Arcadia Biosciences Reports 2024 Results, Faces Going Concern Uncertainty Amid Proposed Roosevelt Resources Exchange
Arcadia Biosciences' 2024 10-K filing reveals a year of strategic asset sales, ongoing losses, and substantial doubt about its ability to continue as a going concern, all while pursuing a business combination with Roosevelt Resources LP.
NASDAQ
RKDA
Arcadia Biosciences, INC
10-K/A: Arcadia Biosciences Files Amended 10-K Report, Updates Board and Executive Information
Arcadia Biosciences has filed an amendment to its annual report to include previously omitted information regarding directors, executive officers, and corporate governance.
NASDAQ
RKDA
Arcadia Biosciences, INC
10-K: Arcadia Biosciences Details Stock Structure and Anti-Takeover Measures in 10-K Filing
Arcadia Biosciences' 10-K filing outlines its capital structure, including common and preferred stock details, and various provisions designed to deter hostile takeovers.